Moreover, further studies that focus on optimizing sequences based on the binding sites in NUCKS1 mRNA complementary to tRF-T36 could greatly enhance the efficacy of siRNAs designed to suppress colorectal cancer (CRC). Here, NUCKS1 is linked to colorectal carcinoma.